retatrutide trial results news Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Lilly's triple agonist achieves 16.8%

Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed

If more glycemic control or weight loss is needed, the dose can increase to 1 mg and then to the maximum of 2 mg

The abdominal wall has significantly higher subcutaneous blood flow

In FY25, Chemist Warehouse network sales rose 14 per cent, with like-for-like sales up 11.3 per cent

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

Timothy Garvey, MD, professor of medicine and director of the University of Alabama at Birminghams Diabetes Research Center